Open AccessCarfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?
Author(s) -
Monika Engelhardt,
Kwee Yong,
Sara Bringhen,
Ralph Wäsch
Publication year - 2019
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2019.228684
Subject(s) - carfilzomib , medicine , multiple myeloma , oncology , salvage therapy , lenalidomide , chemotherapy